Literature DB >> 3265874

Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats.

J M Murphy1, M B Waller, G J Gatto, W J McBride, L Lumeng, T K Li.   

Abstract

Rats of the alcohol-preferring P line (n = 7) were trained to self-administer ethanol (20% v/v) and water via an intragastric IG catheter. Food was available ad lib. Ethanol intakes averaged approximately 5-6 g/kg body wt./day. Treatment with the serotonin (5-HT) uptake inhibitor fluoxetine (10 mg/kg/day; IG) for seven consecutive days produced a marked decrease in ethanol self-administration on the first day, which was sustained throughout the seven days of treatment to values as low as 1 g/kg/day. Concomitant with the decrease in ethanol intake, the self-infusion of water gradually increased during the period of fluoxetine treatment. Total caloric intake (ethanol plus food) was moderately reduced during fluoxetine treatment; the decrease in food consumption was consistent but not statistically significant. When fluoxetine treatment was terminated, ethanol self-administration quickly returned to the prefluoxetine levels, while water intake began to decrease. Since no ethanol was consumed orally, the IG ethanol was not self-administered for its taste or smell, but apparently for its postingestive pharmacological effects. The robust reduction of ethanol self-infusion that occurred with fluoxetine treatment suggests that the 5-HT systems are involved in the reinforcing effects of ethanol in the P line of rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265874     DOI: 10.1016/0741-8329(88)90066-3

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  21 in total

Review 1.  Preclinical studies of alcohol binge drinking.

Authors:  John C Crabbe; R Adron Harris; George F Koob
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  An experimental approach to understanding the genetic and neurobiological basis of alcoholism.

Authors:  T K Li; L Lumeng; W J McBride; J M Murphy
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

3.  Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

Authors:  F Weiss; M Mitchiner; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 5.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 6.  Selective breeding for alcohol preference and associated responses.

Authors:  T K Li; L Lumeng; D P Doolittle
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

7.  Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.

Authors:  R Schreiber; K Opitz; T Glaser; J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 9.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

Review 10.  Comparative efficacy of antidepressants.

Authors:  S Kasper; J Fuger; H J Möller
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.